Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
OTTAWA (dpa-AFX) - Tuesday, Kyowa Kirin (4151.T) said it entered into an exclusive distribution agreement with Knight Therapeutics (GUD.TO) for POTELIGEO (mogamulizumab) in select Latin American countries.Under the agreement, Knight will seek regulatory approvals and commercialize POTELIGEO for myc…
Kyowa Kirin International, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced the signing of an exclusive distribution agreement with Knight Therapeutics (“Knight”) (TSX:GUD) for the distribution of mogamulizumab in select countries in Latin America.Under th…
Knight Therapeutics says it will seek regulatory approval and then commercialize Poteligeo (mogamulizumab) in Brazil, Mexico, Colombia and Argentina under an exclusive distribution agreement with Kyowa Kirin International.